BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 20668261)

  • 1. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations.
    Bäumer D; Hilton D; Paine SM; Turner MR; Lowe J; Talbot K; Ansorge O
    Neurology; 2010 Aug; 75(7):611-8. PubMed ID: 20668261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions.
    Huang EJ; Zhang J; Geser F; Trojanowski JQ; Strober JB; Dickson DW; Brown RH; Shapiro BE; Lomen-Hoerth C
    Brain Pathol; 2010 Nov; 20(6):1069-76. PubMed ID: 20579074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALS-FUS pathology revisited: singleton FUS mutations and an unusual case with both a FUS and TARDBP mutation.
    King A; Troakes C; Smith B; Nolan M; Curran O; Vance C; Shaw CE; Al-Sarraj S
    Acta Neuropathol Commun; 2015 Oct; 3():62. PubMed ID: 26452761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autopsied case of sporadic adult-onset amyotrophic lateral sclerosis with FUS-positive basophilic inclusions.
    Matsuoka T; Fujii N; Kondo A; Iwaki A; Hokonohara T; Honda H; Sasaki K; Suzuki SO; Iwaki T
    Neuropathology; 2011 Feb; 31(1):71-6. PubMed ID: 20573033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation.
    Mackenzie IR; Ansorge O; Strong M; Bilbao J; Zinman L; Ang LC; Baker M; Stewart H; Eisen A; Rademakers R; Neumann M
    Acta Neuropathol; 2011 Jul; 122(1):87-98. PubMed ID: 21604077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid.
    Bigio EH; Wu JY; Deng HX; Bit-Ivan EN; Mao Q; Ganti R; Peterson M; Siddique N; Geula C; Siddique T; Mesulam M
    Acta Neuropathol; 2013 Mar; 125(3):463-5. PubMed ID: 23378033
    [No Abstract]   [Full Text] [Related]  

  • 7. Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease.
    Ito H; Fujita K; Nakamura M; Wate R; Kaneko S; Sasaki S; Yamane K; Suzuki N; Aoki M; Shibata N; Togashi S; Kawata A; Mochizuki Y; Mizutani T; Maruyama H; Hirano A; Takahashi R; Kawakami H; Kusaka H
    Acta Neuropathol; 2011 Apr; 121(4):555-7. PubMed ID: 21327942
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
    Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
    Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation.
    Aizawa H; Hideyama T; Yamashita T; Kimura T; Suzuki N; Aoki M; Kwak S
    J Clin Neurosci; 2016 Oct; 32():128-9. PubMed ID: 27343041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic Features of FUS Inclusions in Spinal Motor Neurons of Sporadic Amyotrophic Lateral Sclerosis.
    Ikenaka K; Ishigaki S; Iguchi Y; Kawai K; Fujioka Y; Yokoi S; Abdelhamid RF; Nagano S; Mochizuki H; Katsuno M; Sobue G
    J Neuropathol Exp Neurol; 2020 Apr; 79(4):370-377. PubMed ID: 32142134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined fused in sarcoma-positive (FUS+) basophilic inclusion body disease and atypical tauopathy presenting with an amyotrophic lateral sclerosis/motor neurone disease (ALS/MND)-plus phenotype.
    Wharton SB; Verber NS; Wagner BE; Highley JR; Fillingham DJ; Waller R; Strand K; Ince PG; Shaw PJ
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):586-596. PubMed ID: 30659642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
    Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M
    J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
    Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
    Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
    Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
    Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
    Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
    Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and pathological characteristics of FUS/TLS-associated amyotrophic lateral sclerosis (ALS)].
    Murayama S
    Rinsho Shinkeigaku; 2010 Nov; 50(11):948-50. PubMed ID: 21921522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43).
    Bentmann E; Neumann M; Tahirovic S; Rodde R; Dormann D; Haass C
    J Biol Chem; 2012 Jun; 287(27):23079-94. PubMed ID: 22563080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation.
    Tateishi T; Hokonohara T; Yamasaki R; Miura S; Kikuchi H; Iwaki A; Tashiro H; Furuya H; Nagara Y; Ohyagi Y; Nukina N; Iwaki T; Fukumaki Y; Kira J
    Acta Neuropathol; 2010 Mar; 119(3):355-64. PubMed ID: 19967541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical FTLD-FUS associated with ALS-TDP: a case report.
    Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H
    Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo FUS gene mutations are associated with juvenile-onset sporadic amyotrophic lateral sclerosis in China.
    Zou ZY; Cui LY; Sun Q; Li XG; Liu MS; Xu Y; Zhou Y; Yang XZ
    Neurobiol Aging; 2013 Apr; 34(4):1312.e1-8. PubMed ID: 23046859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.